|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar
|
|
2
|
von der Maase H, Sengelov L, Roberts JT,
et al: Long-term survival results of a randomized trial comparing
gemcitabine plus cisplatin, with methotrexate, vinblastine,
doxorubicin, plus cisplatin in patients with bladder cancer. J Clin
Oncol. 23:4602–4608. 2005.
|
|
3
|
Mongroo PS and Rustgi AK: The role of the
miR-200 family in epithelial-mesenchymal transition. Cancer Biol
Ther. 10:219–222. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wiklund ED, Bramsen JB, Hulf T, et al:
Coordinated epigenetic repression of the miR-200 family and miR-205
in invasive bladder cancer. Int J Cancer. 128:1327–1334. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li Y, Yang K, Mao Q, et al: Inhibition of
TGF-beta receptor I by siRNA suppresses the motility and
invasiveness of T24 bladder cancer cells via modulation of
integrins and matrix metalloproteinase. Int Urol Nephrol.
42:315–323. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Michl P, Ramjaun AR, Pardo OE, et al:
CUTL1 is a target of TGF(beta) signaling that enhances cancer cell
motility and invasiveness. Cancer Cell. 7:521–532. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Subramanian G, Schwarz RE, Higgins L, et
al: Targeting endogenous transforming growth factor beta receptor
signaling in SMAD4-deficient human pancreatic carcinoma cells
inhibits their invasive phenotype1. Cancer Res.
64:5200–5211. 2004. View Article : Google Scholar
|
|
8
|
Liu J, van Mil A, Aguor EN, et al: MiR-155
inhibits cell migration of human cardiomyocyte progenitor cells
(hCMPCs) via targeting of MMP-16. J Cell Mol Med. 16:2379–2386.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mamuya FA and Duncan MK: aV integrins and
TGF-β-induced EMT: a circle of regulation. J Cell Mol Med.
16:445–455. 2012.
|
|
10
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gottardo F, Liu CG, Ferracin M, et al:
Micro-RNA profiling in kidney and bladder cancers. Urol Oncol.
25:387–392. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dyrskjøt L, Ostenfeld MS, Bramsen JB, et
al: Genomic profiling of microRNAs in bladder cancer: miR-129 is
associated with poor outcome and promotes cell death in vitro.
Cancer Res. 69:4851–4860. 2009.PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−ΔΔCT) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Slabáková E, Pernicová Z, Slavíčková E, et
al: TGF-β1-induced EMT of non-transformed prostate hyperplasia
cells is characterized by early induction of SNAI2/Slug. Prostate.
71:1332–1343. 2011.
|
|
15
|
Koo V, El Mekabaty A, Hamilton P, et al:
Novel in vitro assays for the characterization of EMT in
tumourigenesis. Cell Oncol. 32:67–76. 2010.PubMed/NCBI
|
|
16
|
Zheng Q, Safina A and Bakin AV: Role of
high-molecular weight tropomyosins in TGF-beta-mediated control of
cell motility. Int J Cancer. 122:78–90. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gregory PA, Bert AG, Paterson EL, et al:
The miR-200 family and miR-205 regulate epithelial to mesenchymal
transition by targeting ZEB1 and SIP1. Nat Cell Biol. 10:593–601.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Starsíchová A, Lincová E, Pernicová Z, et
al: TGF-beta1 suppresses IL-6-induced STAT3 activation through
regulation of Jak2 expression in prostate epithelial cells. Cell
Signal. 22:1734–1744. 2010.PubMed/NCBI
|
|
19
|
Chan YC, Khanna S, Roy S and Sen CK:
miR-200b targets Ets-1 and is down-regulated by hypoxia to induce
angiogenic response of endothelial cells. J Biol Chem.
286:2047–2056. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hurteau GJ, Carlson JA, Spivack SD and
Brock GJ: Overexpression of the microRNA hsa-miR-200c leads to
reduced expression of transcription factor 8 and increased
expression of E-cadherin. Cancer Res. 67:7972–7976. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hurteau GJ, Carlson JA, Roos E and Brock
GJ: Stable expression of miR-200c alone is sufficient to regulate
TCF8 (ZEB1) and restore E-cadherin expression. Cell Cycle.
8:2064–2069. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Korpal M, Lee ES, Hu G and Kang Y: The
miR-200 family inhibits epithelial-mesenchymal transition and
cancer cell migration by direct targeting of E-cadherin
transcriptional repressors ZEB1 and ZEB2. J Biol Chem.
283:14910–14914. 2008. View Article : Google Scholar
|
|
23
|
Li Y, Wang Y, Yu L, et al: miR-146b-5p
inhibits glioma migration and invasion by targeting MMP16. Cancer
Lett. 339:260–269. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xia H, Qi Y, Ng SS, et al: microRNA-146b
inhibits glioma cell migration and invasion by targeting MMPs.
Brain Res. 1269:158–165. 2009. View Article : Google Scholar : PubMed/NCBI
|
